Theravance Biopharma TBPH Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
Based on the most recent quarter.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Theravance Biopharma's quick ratio?
- Theravance Biopharma (TBPH) reported quick ratio of 13.1× in Q1 2026.
- How has Theravance Biopharma's quick ratio changed year-over-year?
- Theravance Biopharma's quick ratio increased by 175.5% year-over-year, from 4.8× to 13.1×.
- What is the long-term trend for Theravance Biopharma's quick ratio?
- Over 5 years (2020 to 2025), Theravance Biopharma's quick ratio has grown at a 28.0% compound annual growth rate (CAGR), from 3.2× to 10.9×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.